Type 1 Diabetes Research

A Step Into Freedom From T1DM

Saturday, 21 August 2021


Coronavirus disease 2019 (COVID-19) has stimulated health concerns globally, especially in diabetes where it has been accompanied by severe outcomes.

Type 2 diabetes mellitus (T2DM) is a chief worry; though, there are a considerable population of patients with type 1 diabetes mellitus (T1DM) also, that too with incomparable concerns during the current COVID-19 pandemic. Some children experience significant complications related to this disease and paediatric deaths have also been reported.

This article describes some key points related to the complications and management of concomitant T1DM and COVID-19.

Read Full Article

Source: Dr. D. Y. Patil Institute of Pharmaceutical Sciences & Research Blog

Keywords: Blood Glucose, Diabetes, COVID-19, Insulin    

Dr Shivani Desai is a clinical pharmacist, an experienced clinical researcher and academician. She leads preclinical and clinical projects at Serum Institute of India, Pune, India. She expertises in Type 1 Diabetes Mellitus (T1DM) and is currently researching its prevention and reversal.

2 comments:

  1. Some evidence there, in Diabetes, after covid those people recover without medicine, their natural antibody somewhat help in beta cell regeneration. Same in opposite, those taken excessive medicine, diabetic level became worst.

    ReplyDelete

Testimonials

Collaborate With Me

Contact Us

SHIVANI DESAI
+91-20-4930-0148
Pune, India